Today’s stock to be analyzed is Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer. By 2008 Glenmark was the fifth-biggest pharmaceutical company in India.
In 2020, it launched a Covid-19 drug under Brand Name #FabiFlu. It is the first oral #favipiravir approved medication in India for the treatment of #Covid-19.
This post contains the fundamental as well as technical analysis of Glenmark pharmaceuticals stock.